On June 15, 2022, Inhibrx, Inc. and Oxford Finance LLC entered into a fifth amendment to the Loan and Security Agreement between the Company and Oxford, dated as of July 15, 2020, as amended by the First Amendment dated November 12, 2020, the Second Amendment dated December 15, 2020, the Third Amendment dated June 18, 2021, and the Fourth Amendment dated February 18, 2022. The Fifth Amendment amends and restates the Fifth Draw Period and Sixth Draw Period (each as defined in the Fourth Amendment) to end on the earlier of (i) June 30, 2022 and (ii) the occurrence of an Event of Default (as defined in the Loan and Security Agreement). Except as noted above, the terms of the Oxford Loan Agreement remain unchanged.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
34.42 USD | -0.04% | +1.38% | -9.26% |
Feb. 28 | Inhibrx Shares Fall After Q4 Net Loss Widens | MT |
Feb. 28 | Earnings Flash (INBX) INHIBRX Reports Q4 Revenue $1.6M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.26% | 1.63B | |
+2.63% | 108B | |
+9.78% | 105B | |
+0.76% | 23.46B | |
-12.15% | 21.72B | |
-7.05% | 18.64B | |
-38.55% | 17.45B | |
-7.41% | 17.19B | |
+5.91% | 13.99B | |
+35.06% | 12.53B |
- Stock Market
- Equities
- INBX Stock
- News Inhibrx, Inc.
- Inhibrx, Inc. and Oxford Finance LLC Enter into A Fifth Amendment to the Loan and Security Agreement